Ocular side effects associated with bisphosphonates

Frederick W. Fraunfelder

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the management of hypercalcemia of malignancy. Recently, some drugs within this class of medicines have been proven to cause scleritis. Prior to this, bisphosphonates had been reported to cause a variety of ocular side effects, most of which are inflammatory. This review discusses the many different medicines called bisphosphonates and highlights the ocular side effect profile of each. In cases where information on dechallenge is provided, all the ocular side effects resolved after discontinuation of the medication. Recognition of adverse ocular events in association with bisphosphonate therapy should alert clinicians to the need for ophthalmic evaluation and the consideration of discontinuation of therapy in all cases of scleritis.

Original languageEnglish (US)
Pages (from-to)829-835
Number of pages7
JournalDrugs of Today
Volume39
Issue number11
DOIs
StatePublished - Nov 2003

Fingerprint

Diphosphonates
Scleritis
Hypercalcemia
Bone Resorption
Therapeutics
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Ocular side effects associated with bisphosphonates. / Fraunfelder, Frederick W.

In: Drugs of Today, Vol. 39, No. 11, 11.2003, p. 829-835.

Research output: Contribution to journalArticle

Fraunfelder, Frederick W. / Ocular side effects associated with bisphosphonates. In: Drugs of Today. 2003 ; Vol. 39, No. 11. pp. 829-835.
@article{4173a6a81dcc45a2a3d7d3ed9ab4d802,
title = "Ocular side effects associated with bisphosphonates",
abstract = "Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the management of hypercalcemia of malignancy. Recently, some drugs within this class of medicines have been proven to cause scleritis. Prior to this, bisphosphonates had been reported to cause a variety of ocular side effects, most of which are inflammatory. This review discusses the many different medicines called bisphosphonates and highlights the ocular side effect profile of each. In cases where information on dechallenge is provided, all the ocular side effects resolved after discontinuation of the medication. Recognition of adverse ocular events in association with bisphosphonate therapy should alert clinicians to the need for ophthalmic evaluation and the consideration of discontinuation of therapy in all cases of scleritis.",
author = "Fraunfelder, {Frederick W.}",
year = "2003",
month = "11",
doi = "10.1358/dot.2003.39.11.799461",
language = "English (US)",
volume = "39",
pages = "829--835",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "11",

}

TY - JOUR

T1 - Ocular side effects associated with bisphosphonates

AU - Fraunfelder, Frederick W.

PY - 2003/11

Y1 - 2003/11

N2 - Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the management of hypercalcemia of malignancy. Recently, some drugs within this class of medicines have been proven to cause scleritis. Prior to this, bisphosphonates had been reported to cause a variety of ocular side effects, most of which are inflammatory. This review discusses the many different medicines called bisphosphonates and highlights the ocular side effect profile of each. In cases where information on dechallenge is provided, all the ocular side effects resolved after discontinuation of the medication. Recognition of adverse ocular events in association with bisphosphonate therapy should alert clinicians to the need for ophthalmic evaluation and the consideration of discontinuation of therapy in all cases of scleritis.

AB - Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the management of hypercalcemia of malignancy. Recently, some drugs within this class of medicines have been proven to cause scleritis. Prior to this, bisphosphonates had been reported to cause a variety of ocular side effects, most of which are inflammatory. This review discusses the many different medicines called bisphosphonates and highlights the ocular side effect profile of each. In cases where information on dechallenge is provided, all the ocular side effects resolved after discontinuation of the medication. Recognition of adverse ocular events in association with bisphosphonate therapy should alert clinicians to the need for ophthalmic evaluation and the consideration of discontinuation of therapy in all cases of scleritis.

UR - http://www.scopus.com/inward/record.url?scp=0347717760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347717760&partnerID=8YFLogxK

U2 - 10.1358/dot.2003.39.11.799461

DO - 10.1358/dot.2003.39.11.799461

M3 - Article

C2 - 14702129

AN - SCOPUS:0347717760

VL - 39

SP - 829

EP - 835

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 11

ER -